[go: up one dir, main page]

HU906436D0 - Process for the production of 3-substituted 2-oxyndole-derivatives - Google Patents

Process for the production of 3-substituted 2-oxyndole-derivatives

Info

Publication number
HU906436D0
HU906436D0 HU906436A HU643690A HU906436D0 HU 906436 D0 HU906436 D0 HU 906436D0 HU 906436 A HU906436 A HU 906436A HU 643690 A HU643690 A HU 643690A HU 906436 D0 HU906436 D0 HU 906436D0
Authority
HU
Hungary
Prior art keywords
substituted
derivatives
oxyndole
production
mammal
Prior art date
Application number
HU906436A
Other languages
English (en)
Other versions
HUT59004A (en
Inventor
Carl Joseph Goddard
Douglas Charles Hanson
Gary Richard Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU906436D0 publication Critical patent/HU906436D0/hu
Publication of HUT59004A publication Critical patent/HUT59004A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU906436A 1989-10-13 1990-10-12 Process for applying the interleukine-1 biosynthesis of 3-substituted-2-oxyndole-derivatives carried out as inhibitor HUT59004A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42144589A 1989-10-13 1989-10-13
US52905090A 1990-05-25 1990-05-25

Publications (2)

Publication Number Publication Date
HU906436D0 true HU906436D0 (en) 1991-04-29
HUT59004A HUT59004A (en) 1992-04-28

Family

ID=27025248

Family Applications (2)

Application Number Title Priority Date Filing Date
HU906436A HUT59004A (en) 1989-10-13 1990-10-12 Process for applying the interleukine-1 biosynthesis of 3-substituted-2-oxyndole-derivatives carried out as inhibitor
HU95P/P00128P HU210902A9 (en) 1989-10-13 1995-05-11 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00128P HU210902A9 (en) 1989-10-13 1995-05-11 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis

Country Status (14)

Country Link
US (1) US5192790A (hu)
EP (1) EP0425109B1 (hu)
JP (1) JPH0684300B2 (hu)
KR (1) KR910007526A (hu)
AT (1) ATE109349T1 (hu)
AU (1) AU624739B2 (hu)
CA (1) CA2027394C (hu)
DE (1) DE69011272T2 (hu)
DK (1) DK0425109T3 (hu)
HU (2) HUT59004A (hu)
IE (1) IE63140B1 (hu)
IL (1) IL95880A (hu)
MY (1) MY106834A (hu)
PT (1) PT95566B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US6266485B1 (en) 1998-02-19 2001-07-24 Emerson Electric Co. One-piece plastic tank and temperature control system for a hot water dispenser
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN162090B (hu) * 1984-03-19 1988-03-26 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
IN161509B (hu) * 1984-05-04 1987-12-19 Pfizer
US4678802A (en) * 1985-07-09 1987-07-07 Pfizer Inc. 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents
GB8517958D0 (en) * 1985-07-16 1985-08-21 Cellena Cell Eng Ag Compositions containing melatonin/homologues
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
US4677132A (en) * 1986-03-12 1987-06-30 American Home Products Corporation Inhibition of bone resorption by etodolac
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives

Also Published As

Publication number Publication date
PT95566B (pt) 1997-11-28
JPH0684300B2 (ja) 1994-10-26
DE69011272D1 (de) 1994-09-08
HUT59004A (en) 1992-04-28
IL95880A (en) 1995-12-31
IE63140B1 (en) 1995-03-22
KR910007526A (ko) 1991-05-30
DE69011272T2 (de) 1994-11-24
HU210902A9 (en) 1995-09-28
CA2027394C (en) 1995-01-03
PT95566A (pt) 1991-08-14
IE903648A1 (en) 1991-04-24
EP0425109A3 (en) 1992-01-15
AU624739B2 (en) 1992-06-18
AU6458290A (en) 1991-04-18
DK0425109T3 (da) 1994-11-21
ATE109349T1 (de) 1994-08-15
JPH03133929A (ja) 1991-06-07
US5192790A (en) 1993-03-09
MY106834A (en) 1995-07-31
CA2027394A1 (en) 1991-04-14
EP0425109A2 (en) 1991-05-02
EP0425109B1 (en) 1994-08-03

Similar Documents

Publication Publication Date Title
LTIP919A (en) Drugs and process for preparing thereof
HUT64699A (en) Process for production of preparations for the treatment of disorders and disearses
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
SG50339A1 (en) Fatty acid derivatives
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
HUT53655A (en) Process for producing pharmaceutical compositions suitable for treating hiv-infected patients
HUT49603A (en) Process for producing tetrazole derivatives and pharmaceutical compositions comprising same
HUT53291A (en) Process for production of medical compositions applicable for treatment of inflammation of diarthrosis
HUT52377A (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient
HUT63577A (en) Process for producing pharmaceutical compositions suitable for intranasal treatment and sprayer for administering such compositions
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
HUT54050A (en) Process for producing pharmaceutical compositions containing pyrimidinyl-piperazine derivatives for treating cerebral deficiency of blood
HUT62193A (en) Process for producing pharmaceutical composition improving the effect of photoageing
HU906436D0 (en) Process for the production of 3-substituted 2-oxyndole-derivatives
EP0435153A3 (en) R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, process for its preparation and medicines containing it
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
EP0516914A3 (en) Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
HUT57051A (en) Pharmaceutical composition for treating tonsilitis and process for producing them
HU9200400D0 (en) Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them
HUT59307A (en) Process for producing pharmaceutical compositions comprising zofenopril and suitable for treating arthritis
ZA898274B (en) 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
IL94942A0 (en) Pharmaceutical compositions containing retinoids for the treatment and prophylaxis of disorders of the immune system
HU213268B (en) Process for producing pharmaceutical composition for treating dermatological diseases
GB8909136D0 (en) Anticonvulsant pyridines and analogues thereof

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal